Home > Healthcare > Medical Devices > Therapeutic Devices > Gastrointestinal Bleeding Treatment Market

Gastrointestinal Bleeding Treatment Market Trends

Report ID: GMI8601
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Gastrointestinal Bleeding Treatment Market Trends

Increasing incidence of gastrointestinal bleeding (GIB) is a significant driver of the market.
Several factors such as rising aging population coupled with increasing prevalence of gastrointestinal disorders such as peptic ulcers, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD), as well as the growing use of NSAID’s is contribution to the increasing cases of GI tract bleeding.
For instance, as per the National Institute of Health (NIH), peptic ulcer disease (PUD) affects four million people worldwide annually and has an estimated lifetime prevalence of 5−10% in the general population.
Additionally, lifestyle factors such as smoking, excessive alcohol consumption, and poor dietary habits also play a role in the development of GI bleeding.
Thus, as the incidence of GI bleeding continues to rise, there is a growing need for effective treatments to manage this condition and its complications, driving the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Gastrointestinal bleeding treatment market size was USD 808 million in 2023 and is expected to register 7.9% CAGR from 2024-2032 owing to the rising cases of gastrointestinal disorders such as peptic ulcers, gastritis, and colorectal cancer worldwide.

Gastrointestinal bleeding treatment industry from the endoscopic hemostatic devices segment recorded USD 498.8 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their high efficacy and minimally invasive nature.

North America gastrointestinal bleeding treatment industry held 41.6% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the high prevalence of gastrointestinal disorders in the region.

CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc., STERIS PLC, and US Medical Innovations, are some of the major gastrointestinal bleeding treatment companies worldwide.